aspirin and semaglutide Weight loss drug could reduce heart attack risk by 20%, study finds | Medical research Retatrutide for weight loss: Study

A hard lump from lipohypertrophy (injecting in the same spot repeatedly) can take weeks to months to resolve

Most patients report mild to moderate fatigue during the first month

Glycemic mechanism and insulin sparing sensitization not secretion: fasting insulin and C-peptide fall while insulin sensitivity (HOMA2-%S) rises +31.8/+43.2/+49.9% (SURPASS J-mono, Hamamoto 2025)

People who accepted Semaglutide dropped 12.4 % of their primary body weight compared to individuals who received a placebo

Note that DPP-4 inhibitors should not be used concurrently with GLP-1 receptor agonists due to overlapping mechanisms

In the self-controlled case series design, use of GLP-1 RAs was associated with a lower incidence rate ratio (IRR) of suicide or suicide attempts one year after treatment initiation (IRR: 0.45